275 related articles for article (PubMed ID: 27550453)
1. WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
Del Mare S; Husanie H; Iancu O; Abu-Odeh M; Evangelou K; Lovat F; Volinia S; Gordon J; Amir G; Stein J; Stein GS; Croce CM; Gorgoulis V; Lian JB; Aqeilan RI
Cancer Res; 2016 Oct; 76(20):6107-6117. PubMed ID: 27550453
[TBL] [Abstract][Full Text] [Related]
2. WWOX promotes osteosarcoma development via upregulation of Myc.
Akkawi R; Hidmi O; Haj-Yahia A; Monin J; Diment J; Drier Y; Stein GS; Aqeilan RI
Cell Death Dis; 2024 Jan; 15(1):13. PubMed ID: 38182577
[TBL] [Abstract][Full Text] [Related]
3. Conditional inactivation of the mouse Wwox tumor suppressor gene recapitulates the null phenotype.
Abdeen SK; Del Mare S; Hussain S; Abu-Remaileh M; Salah Z; Hagan J; Rawahneh M; Pu XA; Russell S; Stein JL; Stein GS; Lian JB; Aqeilan RI
J Cell Physiol; 2013 Jul; 228(7):1377-82. PubMed ID: 23254685
[TBL] [Abstract][Full Text] [Related]
4. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.
Kurek KC; Del Mare S; Salah Z; Abdeen S; Sadiq H; Lee SH; Gaudio E; Zanesi N; Jones KB; DeYoung B; Amir G; Gebhardt M; Warman M; Stein GS; Stein JL; Lian JB; Aqeilan RI
Cancer Res; 2010 Jul; 70(13):5577-86. PubMed ID: 20530675
[TBL] [Abstract][Full Text] [Related]
5. Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.
Yang J; Zhao L; Tian W; Liao Z; Zheng H; Wang G; Chen K
BMC Med Genomics; 2013 Dec; 6():56. PubMed ID: 24330824
[TBL] [Abstract][Full Text] [Related]
6. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism.
Aqeilan RI; Hassan MQ; de Bruin A; Hagan JP; Volinia S; Palumbo T; Hussain S; Lee SH; Gaur T; Stein GS; Lian JB; Croce CM
J Biol Chem; 2008 Aug; 283(31):21629-39. PubMed ID: 18487609
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell signaling and apoptosis by tumor suppressor WWOX.
Lo JY; Chou YT; Lai FJ; Hsu LJ
Exp Biol Med (Maywood); 2015 Mar; 240(3):383-91. PubMed ID: 25595191
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.
Yang J; Cogdell D; Yang D; Hu L; Li H; Zheng H; Du X; Pang Y; Trent J; Chen K; Zhang W
Cancer Lett; 2010 May; 291(1):31-8. PubMed ID: 19896763
[TBL] [Abstract][Full Text] [Related]
9. Deregulated WWOX is involved in a negative feedback loop with microRNA-214-3p in osteosarcoma.
Gao K; Yin J; Dong J
Int J Mol Med; 2016 Dec; 38(6):1850-1856. PubMed ID: 27840941
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
[TBL] [Abstract][Full Text] [Related]
11. WWOX: a fragile tumor suppressor.
Schrock MS; Huebner K
Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
[TBL] [Abstract][Full Text] [Related]
12. A p53/TIAF1/WWOX triad exerts cancer suppression but may cause brain protein aggregation due to p53/WWOX functional antagonism.
Chou PY; Lin SR; Lee MH; Schultz L; Sze CI; Chang NS
Cell Commun Signal; 2019 Jul; 17(1):76. PubMed ID: 31315632
[TBL] [Abstract][Full Text] [Related]
13. Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.
Liu SY; Chiang MF; Chen YJ
Exp Biol Med (Maywood); 2015 Mar; 240(3):315-23. PubMed ID: 25432984
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of Wwox reveals a tumor suppressor function.
Aqeilan RI; Trapasso F; Hussain S; Costinean S; Marshall D; Pekarsky Y; Hagan JP; Zanesi N; Kaou M; Stein GS; Lian JB; Croce CM
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3949-54. PubMed ID: 17360458
[TBL] [Abstract][Full Text] [Related]
15. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
[No Abstract] [Full Text] [Related]
16. Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.
Del Mare S; Kurek KC; Stein GS; Lian JB; Aqeilan RI
Am J Cancer Res; 2011; 1(5):585-94. PubMed ID: 21731849
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
[TBL] [Abstract][Full Text] [Related]
18. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
[TBL] [Abstract][Full Text] [Related]
19. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.
Kansara M; Tsang M; Kodjabachian L; Sims NA; Trivett MK; Ehrich M; Dobrovic A; Slavin J; Choong PF; Simmons PJ; Dawid IB; Thomas DM
J Clin Invest; 2009 Apr; 119(4):837-51. PubMed ID: 19307728
[TBL] [Abstract][Full Text] [Related]
20. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
